Electroretinogram - Global Strategic Business Report

The global market for Electroretinogram was estimated at US$1.4 Billion in 2024 and is projected to reach US$2.1 Billion by 2030, growing at a CAGR of 7.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Electroretinogram market.

Global Electroretinogram Market - Key Trends & Drivers Summarized

What Is an Electroretinogram, and Why Is It Essential in Ophthalmology?

An electroretinogram (ERG) is a diagnostic test used to measure the electrical response of the retina to light stimulation, providing critical insights into the functional status of the retinal cells, particularly the photoreceptors and inner retinal layers. This non-invasive procedure is widely used in diagnosing a range of retinal disorders, including retinitis pigmentosa, cone-rod dystrophy, Leber's congenital amaurosis, and diabetic retinopathy. With the rising prevalence of retinal diseases due to aging populations, diabetes, and genetic conditions, ERG testing has become increasingly significant in both clinical and research settings. Technological advancements have led to the development of multifocal ERG (mfERG) and pattern ERG (pERG), which offer higher precision and better localization of retinal dysfunction. Additionally, portable and handheld ERG devices are gaining traction due to their convenience in point-of-care settings. The growing integration of artificial intelligence (AI) in retinal diagnostics has also enhanced the interpretation of ERG results, enabling faster and more accurate detection of early-stage retinal disorders. As the field of ophthalmology continues to embrace precision medicine, ERG testing is expected to play a more pivotal role in personalized treatment planning and monitoring disease progression.

How Are Technological Innovations Transforming the Electroretinogram Market?

The electroretinogram market has witnessed significant technological progress in recent years, particularly in terms of device miniaturization, improved electrode designs, and software-driven analytical tools. Traditional ERG systems required extensive setup and calibration, but modern advancements have led to the development of wireless and non-invasive electrodes that enhance patient comfort and test accuracy. The adoption of photopic negative response (PhNR) ERG has expanded applications beyond conventional retinal diagnostics to include early detection of glaucoma and optic nerve diseases. Another breakthrough in ERG technology is the integration of cloud-based platforms that enable remote analysis of ERG data, facilitating telemedicine solutions for retinal care. Furthermore, advancements in signal processing algorithms have significantly reduced noise artifacts, improving the reliability of ERG readings in clinical and research applications. Researchers are also exploring the potential of artificial intelligence (AI) and machine learning (ML) to automate ERG analysis, further accelerating diagnostic efficiency. With the continued evolution of electrophysiology techniques, the next generation of ERG devices is expected to offer even greater precision, speed, and accessibility, broadening their application in various medical specialties.

Which Factors Are Driving the Growing Demand for Electroretinography?

The increasing prevalence of retinal and neuro-ophthalmic disorders is the primary driver of demand for electroretinography. With the global rise in diabetes cases, diabetic retinopathy has emerged as a leading cause of blindness, necessitating early and accurate diagnosis through ERG testing. Similarly, age-related macular degeneration (AMD) and inherited retinal dystrophies are becoming more prevalent, further driving the adoption of ERG in ophthalmology clinics and research institutions. Pediatric ophthalmology has also benefited from advancements in ERG technology, as early detection of congenital retinal disorders can improve clinical outcomes through timely interventions. Beyond ophthalmology, ERG is increasingly used in neurological studies, particularly for evaluating retinal biomarkers in neurodegenerative diseases such as Parkinson's and Alzheimer's. The growing availability of portable ERG systems has expanded its adoption in point-of-care diagnostics, allowing for efficient screening in non-hospital settings. Moreover, pharmaceutical and biotechnology companies are leveraging ERG testing in clinical trials to assess the retinal safety profiles of new drug candidates, reinforcing the importance of ERG in drug development and regulatory approvals.

What Is Driving the Growth of the Electroretinogram Market?

The growth in the electroretinogram market is driven by several factors, including advancements in diagnostic imaging technologies, increasing investment in ophthalmic research, and the rising demand for early disease detection solutions. The development of handheld and portable ERG devices has significantly increased accessibility, particularly in emerging markets where healthcare infrastructure is still developing. The integration of AI-driven analytics in ERG interpretation has also improved diagnostic precision, reducing the dependence on specialized electrophysiologists. Additionally, the expansion of teleophthalmology services has driven the need for remote diagnostic solutions, making ERG devices more relevant in modern healthcare settings. The pharmaceutical industry's growing reliance on ERG for ophthalmic drug safety testing has further accelerated market growth, as regulatory agencies increasingly require comprehensive visual function assessments in clinical trials. Moreover, government initiatives focused on preventing blindness and improving eye health, particularly in aging populations, have led to increased funding for ophthalmic diagnostic devices, including ERG systems. As the field of personalized medicine advances, ERG is expected to play a critical role in tailoring treatment strategies for retinal diseases, positioning it as a key growth area in the broader ophthalmic diagnostics market.

Scope of Study:

The report analyzes the Electroretinogram market in terms of units by the following Segments, and Geographic Regions/Countries:

• Segments: Type (Full-field flash ERG, Pattern ERG, Multifocal ERG); Product (Handheld, Tabletop); Application (Clinical Diagnostic, Research)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Full-field flash ERG segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8.5%. The Pattern ERG segment is also set to grow at 5.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $368.1 Million in 2024, and China, forecasted to grow at an impressive 11.7% CAGR to reach $441.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Electroretinogram Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Electroretinogram Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Electroretinogram Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Allison Medical, Bio-Rad Laboratories, Cadwell Industries, Inc., ChongQing SunKingdom Medical Instrument, CSO Italia and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 34 companies featured in this Electroretinogram market report include:

• Allison Medical
• Bio-Rad Laboratories
• Cadwell Industries, Inc.
• ChongQing SunKingdom Medical Instrument
• CSO Italia
• Diagnosys LLC
• Diopsys, Inc.
• Electro-Diagnostic Imaging, Inc.
• Fabrinal
• Haag-Streit Group
• HEINE Optotechnik
• Konan Medical USA, Inc.
• LKC Technologies, Inc.
• Marco Ophthalmic
• Metrovision
• M&S Technologies
• Neurosoft
• NIDEK Co., Ltd.
• Ocular Instruments
• Opto-Medic Co Pte Ltd

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.